Finally, SComatic also identified subclonal deleterious mutations in cancer driver genes frequently mutated in the cancer types analyzed, such as MLH1, TGFBR2 and KRAS in colorectal tumors (Supplementary Fig. 18), indicating that SComatic can discover subclonal driver mutations. This evidence concerns the gene KRAS and colorectal neoplasm.